{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:13:06Z","timestamp":1761894786524},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.leukres.2008.09.011","type":"journal-article","created":{"date-parts":[[2008,10,19]],"date-time":"2008-10-19T08:08:07Z","timestamp":1224403687000},"page":"366-367","source":"Crossref","is-referenced-by-count":19,"title":["Non-hemic autoimmunity in CLL"],"prefix":"10.1016","volume":"33","author":[{"given":"Terry J.","family":"Hamblin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2008.09.011_bib1","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/jcp.39.7.713","article-title":"Autoimmunity in chronic lymphocytic leukaemia","volume":"39","author":"Hamblin","year":"1986","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.leukres.2008.09.011_bib2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/j.seminoncol.2006.01.011","article-title":"Autoimmune complications of chronic lymphocytic leukemia","volume":"33","author":"Hamblin","year":"2006","journal-title":"Sem Oncol"},{"key":"10.1016\/j.leukres.2008.09.011_bib3","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1182\/blood.V90.7.2701","article-title":"Identification of T-cell epitopes on the Rhesus polypeptides in autoimmune hemolytic anemia","volume":"90","author":"Barker","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.09.011_bib4","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2003-10-3563","article-title":"Rh autoantigen presentation to helper T cells in chronic lymphocytic leukemia by malignant B cells","volume":"105","author":"Hall","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.09.011_bib5","series-title":"Chronic Lymphoid Leukemias","first-page":"435","article-title":"Autoimmune disease and its management in chronic lymphocytic leukemia","author":"Hamblin","year":"2001"},{"key":"10.1016\/j.leukres.2008.09.011_bib6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2141.1995.tb05300.x","article-title":"Fludarabine-related AIHA in patients with chronic lymphocytic leukaemia","volume":"91","author":"Myint","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2008.09.011_bib7","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood-2005-02-0642","article-title":"Reduced frequencies and suppressive function of CD4+ CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine","volume":"106","author":"Beyer","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.09.011_bib8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.immunol.18.1.423","article-title":"Regulatory T cells in autoimmunity","volume":"18","author":"Shevak","year":"2000","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.leukres.2008.09.011_bib9","first-page":"677","article-title":"Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia","volume":"20","author":"Giannopoulos","year":"2008","journal-title":"Oncol Rep"},{"key":"10.1016\/j.leukres.2008.09.011_bib10","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/leu.2008.29","article-title":"Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+ T cells as well as CD4+CD25+FocP3+ regulatory T cells toward an antileukemia response","volume":"22","author":"Hus","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2008.09.011_bib11","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/oxfordjournals.annonc.a059294","article-title":"Lethal paraneoplastic pemphigus following treatment of chronic lymphocytic leukaemia with fludarabine","volume":"6","author":"Bazarbachi","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1016\/j.leukres.2008.09.011_bib12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s002770050347","article-title":"Mucocutaneous autoimmune syndrome following fludarabine therapy for low-grade non-Hodgkin\u2019s lymphoma of B-cell type (B-NHL)","volume":"75","author":"Braess","year":"1997","journal-title":"Ann Hematol"},{"key":"10.1016\/j.leukres.2008.09.011_bib13","first-page":"1102","article-title":"Paraneoplastic pemphigus\u2014an association with fludarabine","volume":"144","author":"Gooplu","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.leukres.2008.09.011_bib14","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1468-3083.2004.00917.x","article-title":"Paraneoplastic pemphigus secondary to fludarabine evolving into unusual oral pemphigus vegetans","volume":"18","author":"Powell","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.leukres.2008.09.011_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF02685912","article-title":"Paraneoplastic pemphigus associated with fludarabine use","volume":"24","author":"Yildiz","year":"2007","journal-title":"Med Oncol"},{"key":"10.1016\/j.leukres.2008.09.011_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jcp.48.2.181","article-title":"Renal failure in a patient with chronic lymphocytic leukaemia treated with fludarabine","volume":"48","author":"Macheta","year":"1995","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.leukres.2008.09.011_bib17","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1093\/oxfordjournals.ndt.a027155","article-title":"Crescentic glomerulonephritis with p-ANCA positivity in fludarabine-treated chronic lymphocytic leukaemia","volume":"11","author":"Tisler","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.leukres.2008.09.011_bib18","article-title":"Nonhematological autoimmunity (glomerulosclerosis, paraneoplastic pehigus and paraneoplastic neurological syndrome) in a patient with chronic lymphocytic leukemia: diagnosis, prognosis and management","author":"Qian","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2008.09.011_bib19","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.leukres.2008.09.011_bib20","first-page":"209","article-title":"CNS involvement in leukaemia. An autopsy study of 100 consecutive patients","volume":"91","author":"Bojsen-M\u01ffller","year":"1983","journal-title":"Acta Pathol Microbiol Immunol Scand A"},{"key":"10.1016\/j.leukres.2008.09.011_bib21","first-page":"600","article-title":"Contrast enhancing lesions in progressive multifocal leukoencephalopathy: a clinicopathological correlation","volume":"14","author":"Shafran","year":"1987","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.leukres.2008.09.011_bib22","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s002779900149","article-title":"Progressive multifocal leukoencephalopathy following oral fludarabine treatment of chronic lymphocytic leukemia","volume":"79","author":"Cid","year":"2000","journal-title":"Ann Hematol"},{"key":"10.1016\/j.leukres.2008.09.011_bib23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/10428190290006297","article-title":"Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia after treatment with fludarabine","volume":"43","author":"Saumoy","year":"2002","journal-title":"Leuk Lymphoma"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608004189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608004189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T12:35:01Z","timestamp":1589027701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212608004189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0145212608004189"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2008.09.011","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}